Valantine Hannah
CIK 0001855608
Director
Filings
29
Latest Mar 12, 2026
Issuers covered
3
Showing
29 of 29
Page 1
Track record
21 of 21 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 21 | 19% | -10.3% | -4.3% | +37.4% | -36.3% |
| 90 days | 20 | 20% | -7.8% | -12.3% | +31.4% | -35.4% |
| 180 days | 18 | 28% | -28.6% | -30.5% | +39.1% | -85.2% |
| 365 days | 11 | 36% | -30.0% | -46.7% | +29.6% | -102.8% |
Issuers
Companies where Valantine Hannah has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BBIO | Bridgebio Pharma, Inc. | 18 | Mar 12, 2026 |
| CDNA | Caredx, Inc. | 7 | Jun 23, 2025 |
| PACB | Pacific Biosciences of California, Inc. | 4 | Jun 6, 2025 |
All filings
29 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|